GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fuse Medical Inc (OTCPK:FZMD) » Definitions » ROA %

Fuse Medical (Fuse Medical) ROA % : 6.53% (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Fuse Medical ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Fuse Medical's annualized Net Income for the quarter that ended in Jun. 2023 was $1.23 Mil. Fuse Medical's average Total Assets over the quarter that ended in Jun. 2023 was $18.88 Mil. Therefore, Fuse Medical's annualized ROA % for the quarter that ended in Jun. 2023 was 6.53%.

The historical rank and industry rank for Fuse Medical's ROA % or its related term are showing as below:

FZMD' s ROA % Range Over the Past 10 Years
Min: -254.3   Med: -2.2   Max: 153.98
Current: 18.96

During the past 13 years, Fuse Medical's highest ROA % was 153.98%. The lowest was -254.30%. And the median was -2.20%.

FZMD's ROA % is ranked better than
97.1% of 863 companies
in the Medical Devices & Instruments industry
Industry Median: -2.04 vs FZMD: 18.96

Fuse Medical ROA % Historical Data

The historical data trend for Fuse Medical's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuse Medical ROA % Chart

Fuse Medical Annual Data
Trend Aug13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.11 -16.35 -8.00 -8.89 16.28

Fuse Medical Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.02 -0.19 73.11 -4.78 6.53

Competitive Comparison of Fuse Medical's ROA %

For the Medical Devices subindustry, Fuse Medical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuse Medical's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fuse Medical's ROA % distribution charts can be found below:

* The bar in red indicates where Fuse Medical's ROA % falls into.



Fuse Medical ROA % Calculation

Fuse Medical's annualized ROA % for the fiscal year that ended in Dec. 2022 is calculated as:

ROA %=Net Income (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=3.098/( (18.304+19.763)/ 2 )
=3.098/19.0335
=16.28 %

Fuse Medical's annualized ROA % for the quarter that ended in Jun. 2023 is calculated as:

ROA %=Net Income (Q: Jun. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Jun. 2023 ))/ count )
=1.232/( (18.433+19.318)/ 2 )
=1.232/18.8755
=6.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jun. 2023) net income data. ROA % is displayed in the 30-year financial page.


Fuse Medical  (OTCPK:FZMD) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2023 )
=Net Income/Total Assets
=1.232/18.8755
=(Net Income / Revenue)*(Revenue / Total Assets)
=(1.232 / 19.988)*(19.988 / 18.8755)
=Net Margin %*Asset Turnover
=6.16 %*1.0589
=6.53 %

Note: The Net Income data used here is four times the quarterly (Jun. 2023) net income data. The Revenue data used here is four times the quarterly (Jun. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Fuse Medical ROA % Related Terms

Thank you for viewing the detailed overview of Fuse Medical's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuse Medical (Fuse Medical) Business Description

Traded in Other Exchanges
N/A
Address
1565 N. Central Expressway, Suite 220, Richardson, TX, USA, 75080
Fuse Medical Inc is a manufacturer and distributor of medical devices. The company provides a comprehensive portfolio of products in the orthopedic total joints, sports medicine, trauma, foot and ankle space, as well as degenerative and deformity spine, orthobiologics, and regenerative medicine.
Executives
Lawrence Scott Yellin director, officer: Chief Financial Officer 5081 PINEVIEW CIRCLE, DELRAY BEACH FL 33445
Christopher C Reeg director, 10 percent owner, officer: Chief Executive Officer 3024 WESTMINSTER AVE, DALLAS TX 75205
Reeg Medical Industries, Inc. 10 percent owner 3024 WESTMINSTER AVE., DALLAS TX 75205
Mark W Brooks 10 percent owner 1565 NORTH CENTRAL EXPRESSWAY, SUITE 200, RICHARDSON TX 75080
Bosita Renato V. Jr. director TEXAS BACK INSTITUTE, 6020 WEST PARKER ROAD #200, PLANO TX 75025
Kalra Ricky Raj S. director 2513 SUNTREE LANE, PLANO TX 75025
Nc 143 Family Holdings, Lp 10 percent owner 1565 NORTH CENTRAL EXPRESSWAY, SUITE 200, RICHARDSON TX 75080
Medtech Family Trust 10 percent owner 1565 NORTH CENTRAL EXPRESSWAY, SUITE 200, RICHARDSON TX 75080
Mclaughlin William E Iii director 1565 NORTH CENTRAL EXPRESSWAY, 2ND FLOOR, RICHARDSON TX 75080
Nc 143 Family Holdings Gp Llc 10 percent owner 1565 NORTH CENTRAL EXPRESSWAY, SUITE 200, RICHARDSON TX 75080
Chris Pratt director, 10 percent owner, officer: Chief Medical Officer 4770 BRYANT IRVIN COURT, SUITE 300, FORT WORTH TX 76107
Randall Dei director, officer: Medical Director of Podiatry 4770 BRYANT IRVIN COURT, SUITE 300, FORT WORTH TX 76107
Rusty Shelton director, 10 percent owner, officer: Chief Development Officer 4770 BRYANT IRVIN COURT, SUITE 300, FORT WORTH TX 76107
David Hexter director, officer: Interim CFO 4770 BRYANT IRVIN COURT, SUITE 300, FORT WORTH TX 76107
D Alan Meeker director, 10 percent owner, officer: Chief Executive Officer 4770 BRYANT IRVIN COURT, SUITE 400, FORT WORTH TX 76107

Fuse Medical (Fuse Medical) Headlines

From GuruFocus